PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

High-dose flu vaccinations resulted in a 23% reduction in hospitalizations among people aged 65 years or older, according to ...

The offer is made at a price of Rs 4,982.05 per share, aggregating to a total consideration of up to Rs 2,983.23 crore, ...

Earlier this month Sanofi revealed talks were ongoing with CD&R, and has now confirmed the negotiations could result in the ...

Globally, buyout deals were on track to finish the year at $521bln, up 18% from 2023, with the rise driven by a higher average deal size rather than more deals ...

Sanofi and CD&R announce a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the ...

Sanofi said its Opella business has been valued at around 16 billion euros (USD17.38 billion), or 14 times EBITDA in 2024 ...

French drama over sovereign paracetamol is really about a deeper ailment: underinvestment.

Plus, James Gorman gets a promotion at Disney and how Jeff Yass turned gambling wins into a colossal trading giant ...

The continent-wide STOXX 600 slipped 0.6%, with the real estate sector leading with a near 2% drop, while energy stocks led ...

PARIS - In the three decades after World War II, Western Europe caught up with the United States in terms of per capita GDP. But since the mid-1990 ...